Welcoming 2026: Strengthening Our Commitment to Reliable and Compliant BA/BE Services

Writer and Editor : Canaya Vania Rehansha

Depok, January 2026 : PT Biometrik Riset Indonesia extends its warmest wishes for a Happy New Year 2026 to all partners, clients, and stakeholders. The beginning of a new year marks an important moment for reflection as well as renewed commitment to delivering high-quality bioavailability and bioequivalence (BA/BE) studies for the pharmaceutical industry.

Reflecting on the Previous Year

Throughout 2025, PT Biometrik Riset Indonesia continued to actively support pharmaceutical companies through the execution of various BA/BE studies. The trust placed in...

PT Biometrik Riset Indonesia Participates in HISFARIN West Java

Writer and Editor : Padantya Narastiti Putri S

Bekasi, December 18th 2025, PT Biometrik Riset Indonesia participated in the HISFARIN (Himpunan Seminat Farmasi Indonesia) event held at Harris Convention Hall, Bekasi. The event brought together various stakeholders from the pharmaceutical industry, including RnD and QA Team.

During the event, PT Biometrik Riset Indonesia team actively engaged with visitors through direct discussions, exchanging insights on analytical testing requirements needs of the pharmaceutical industry, as well as sharing PT Biometrik Riset Indonesia’s experience in condu...

Biometrik Completed Successful Bioequivalence Studies for Ministry of Health Projects 2025

Writer: Devita Nurul Anggraeni Editor: Oktaviani Utami Dewi

Jakarta, December, 22 2025 - PT Biometrik Riset Indonesia has completed bioequivalence studies and reported the results for four molecules on behalf of twelve pharmaceutical industries participating in the Ministry of Health’s Facilitation Program for Local Change of Active Pharmaceutical Ingredient (API) sources. The completed molecules include Sitagliptin, Sitagliptin–Metformin, Rivaroxaban, and Imatinib, covering a total of twelve projects: seven Sitagliptin projects, one Sitagliptin–Metformin project, three Rivaroxaban projects, ...

PT Biometrik Riset Indonesia Reinforces Commitment to National Standards Through BPOM Audit

Writer: dr. Ria Oktavia

Depok, November 24th 2025 – The Bioavailability and Bioequivalence (BA/BE) Center of PT Biometrik Riset Indonesia welcomed an audit by the Indonesian Food and Drug Authority (BPOM) as part of the regulatory assessment to ensure compliance with national standards for BA/BE study implementation.

The audit team from BPOM carried out a comprehensive review of the facilities, including laboratory operations, documentation systems, drug storage conditions, temperature monitoring, operational SOPs, and the conduct of both clinical and bioanalytical phases of the studies.

The ...

PT Biometrik Riset Indonesia Wins Ministry of Health Tender for Bioequivalence Testing Services in 2025

PT Biometrik Riset Indonesia Wins Ministry of Health Tender for Bioequivalence Testing Services in 2025

Writer: Pandu Saputra; Editor: Rizky Puspita Dewi

Jakarta, August 22, 2025 – PT Biometrik Riset Indonesia is proud to announce its success in winning the tender from the Ministry of Health of the Republic of Indonesia (Kemenkes RI) for providing bioequivalence (BE) testing services and facilitation of the change from imported to domestic raw materials for the drugs sitagliptin, imatinib, and rivaroxaban for the 2025 fiscal year.

This renewed trust from the Ministry of Health reinforces PT ...

Sponsor Audit: Biometrik’s Commitment to Quality and Compliance

Writer : Andi Darmawan

On September 10, 2025, PT Biometrik welcomed a sponsor audit at its laboratory facilities. One of the sponsors conducting the audit was PT Tropica Mas Pharmaceuticals, as part of their evaluation to ensure that the laboratory meets all regulatory requirements and international standards before being entrusted with conducting bioequivalence studies.

The audit was carried out over a full day and covered a wide range of critical aspects, including:

• Quality Management System, reviewing standard operating procedures (SOPs), documentation, and quality control workflows implem...

PT Biometrik Riset Indonesia Celebrates 11 Years of Dedication in Research

Writer : Salma Dewina Salimah

Depok, 26 Agustus 2025 – PT Biometrik Riset Indonesia joyfully celebrated its 11th anniversary. This milestone marks an important moment to reflect on more than a decade of the company’s contribution to research, particularly in bioequivalence study and pharmaceutical studies. The celebration, held at PT Biometrik Riset Indonesia’s office on August 26, 2025, was attended by the board of directors, management, and all employees. The event was warm and lively, made even more festive with a traditional batik ‘berkain’ dress code. The program included welcoming rema...

Biometrik Participates in Hisfarin Exhibition: Strengthening Networks and Showcasing Corporate Identity

Writer and Editor : Canaya Vania Rehansha

Semarang, July 35-26, 2025 - PT Biometrik Riset Indonesia successfully participated in the Hisfarin Exhibition held at Hotel MG Setos, Semarang, presenting a booth that combined attractive design with a strategic placement in the main exhibition area. A backdrop, standing banners, and a television screen were installed to maximize visual appeal while reflecting the company’s identity.

Throughout the event, the Biometrik booth became a focal point for interaction with various stakeholders, including prospective sponsors, existing sponsors, event organiz...

PT Biometrik Riset Indonesia Raises Health Awareness Through Basic Life Support Training

Writer: Regina Rahmi Fadila Editor: Oktaviani Utami Dewi

As part of its commitment to employee well-being and emergency preparedness, PT Biometrik Riset Indonesia conducted a Basic Life Support (BLS) training in collaboration with Sentra Medika Hospital on Wednesday, June 25, 2025. The session was led by dr. M. Arief Kurniawan, Sp.An, FIP, a specialist in anaesthesiology and intensive care. This training reflects the company’s proactive approach in fostering a safety-conscious and responsive work environment. PT Biometrik Riset Indonesia firmly believes that basic life support skills are esse...

The Importance of External Quality Assurance (EQA) in Medical Laboratories

Writer and Editor : Tomi Saputra Jaya

Case Study: Participation of Biometrik Medical Laboratory in EQA on June 20, 2025

In the world of medical laboratory services, the accuracy and reliability of test results are critical aspects. To ensure the quality of test results, laboratories rely not only on internal quality control but also need to participate in a broader and more objective quality evaluation system: the External Quality Assurance (EQA) program.

What is External Quality Assurance (EQA)?

EQA is a quality assessment program conducted by an independent external institution. It aims to e...